Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantifying Prescribed-Fire Smoke Exposure Using Low-Cost Sensors and Satellites: Springtime Burning in Eastern Kansas.
Sablan O, Ford B, Gargulinski E, Hammer MS, Henery G, Kondragunta S, Martin RV, Rosen Z, Slater K, van Donkelaar A, Zhang H, Soja AJ, Magzamen S, Pierce JR, Fischer EV. Sablan O, et al. Among authors: slater k. Geohealth. 2024 Mar 28;8(4):e2023GH000982. doi: 10.1029/2023GH000982. eCollection 2024 Apr. Geohealth. 2024. PMID: 38560558 Free PMC article.
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature.
Tonelotto V, Costa-Garcia M, O'Reilly E, Smith KF, Slater K, Dillon ET, Pendino M, Higgins C, Sist P, Bosch R, Passamonti S, Piulats JM, Villanueva A, Tramer F, Vanella L, Carey M, Kennedy BN. Tonelotto V, et al. Among authors: slater k. Cell Death Discov. 2024 Feb 10;10(1):70. doi: 10.1038/s41420-023-01773-8. Cell Death Discov. 2024. PMID: 38341410 Free PMC article.
Empowered Relief, cognitive behavioral therapy, and health education for people with chronic pain: a comparison of outcomes at 6-month Follow-up for a randomized controlled trial.
Darnall BD, Burns JW, Hong J, Roy A, Slater K, Poupore-King H, Ziadni MS, You DS, Jung C, Cook KF, Lorig K, Tian L, Mackey SC. Darnall BD, et al. Among authors: slater k. Pain Rep. 2024 Jan 25;9(1):e1116. doi: 10.1097/PR9.0000000000001116. eCollection 2024 Jan. Pain Rep. 2024. PMID: 38288134 Free PMC article.
Application of multidisciplinary team conference for neuromodulation candidates facilitates patient selection and optimization.
Salmasi V, Rasouli MR, Kao MC, Ottestad E, Terkawi AS, Morris G, Qian X, Coleman S, Talavera DC, Poupore-King H, Slater K, Leong MS. Salmasi V, et al. Among authors: slater k. Front Pain Res (Lausanne). 2024 Jan 5;4:1331883. doi: 10.3389/fpain.2023.1331883. eCollection 2023. Front Pain Res (Lausanne). 2024. PMID: 38249566 Free PMC article.
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Lee AW, Liu K, Lhomme E, Blie J, McCullough J, Onorato MT, Connor L, Simon JK, Dubey S, VanRheenen S, Deutsch J, Owens A, Morgan A, Welebob C, Hyatt D, Nair S, Hamzé B, Guindo O, Sow SO, Beavogui AH, Leigh B, Samai M, Akoo P, Serry-Bangura A, Fleck S, Secka F, Lowe B, Watson-Jones D, Roy C, Hensley LE, Kieh M, Coller BG; PREVAC Study Team. Lee AW, et al. Clin Infect Dis. 2024 Apr 10;78(4):870-879. doi: 10.1093/cid/ciad693. Clin Infect Dis. 2024. PMID: 37967326 Free PMC article. Clinical Trial.
178 results